Literature DB >> 20614857

Upper airway sensory function in children with obstructive sleep apnea syndrome.

Ignacio E Tapia1, Preetam Bandla, Joel Traylor, Laurie Karamessinis, Jingtao Huang, Carole L Marcus.   

Abstract

STUDY
OBJECTIVES: Children with the obstructive sleep apnea syndrome (OSAS) have impaired responses to hypercapnia, subatmospheric pressure, and inspiratory resistive loading during sleep. This may be due, in part, to an impairment in the afferent limb of the upper airway sensory pathway. Therefore, we hypothesized that children with OSAS had diminished upper airway sensation compared to controls.
DESIGN: Case-control.
SETTING: Academic hospital. PARTICIPANTS: Subjects with OSAS aged 6-16 years, and age- and BMI-matched controls.
INTERVENTIONS: Two-point discrimination (TPD) was measured during wakefulness with modified calipers in the anterior tongue, right interior cheek, and hard palate.
RESULTS: Thirteen children with OSAS and 9 controls were tested. The age (mean +/- SD) for OSAS and controls was 11 +/- 4 vs. 13 +/- 2 years (NS); OSAS BMI Z score 2.4 +/- 0.5, controls 2.2 +/- 0.5 (NS); OSAS apnea hypopnea index 31 +/- 48, controls 0.4 +/- 0.5 events/hour (P < 0.001). Children with OSAS had impaired TPD in the anterior tongue (median [range]) = 9 [3-14] mm, controls 3 [1-7], P = 0.002) and hard palate (OSAS 6 [3-9] mm, controls 3 [1-4], P < 0.001). TPD in the cheek was similar between the groups (P = 0.12).
CONCLUSION: TPD in the anterior tongue and hard palate was impaired in children with OSAS during wakefulness. We speculate that this impairment might be due to a primary sensory function abnormality or secondary to nerve damage and/or hypoxemia caused by OSAS. Further studies after treatment of OSAS are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20614857      PMCID: PMC2894439          DOI: 10.1093/sleep/33.7.968

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  58 in total

Review 1.  Oral mucosal versus cutaneous sensory testing: a review of the literature.

Authors:  R Jacobs; C-H Wu; K Goossens; K Van Loven; J Van Hees; D Van Steenberghe
Journal:  J Oral Rehabil       Date:  2002-10       Impact factor: 3.837

2.  Behavior and neurocognitive performance in children aged 5-10 years who snore compared to controls.

Authors:  S Blunden; K Lushington; D Kennedy; J Martin; D Dawson
Journal:  J Clin Exp Neuropsychol       Date:  2000-10       Impact factor: 2.475

3.  Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M E Shy; E M Frohman; Y T So; J C Arezzo; D R Cornblath; M J Giuliani; J C Kincaid; J L Ochoa; G J Parry; L H Weimer
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

4.  Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

5.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

6.  Two-point palatal discrimination in patients with upper airway resistance syndrome, obstructive sleep apnea syndrome, and normal control subjects.

Authors:  Christian Guilleminault; Kasey Li; Ning-Hung Chen; Dalva Poyares
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

7.  Distribution pattern of the human lingual nerve.

Authors:  Karen B Zur; Liancai Mu; Ira Sanders
Journal:  Clin Anat       Date:  2004-03       Impact factor: 2.414

8.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

9.  Adenotonsillectomy improves neurocognitive function in children with obstructive sleep apnea syndrome.

Authors:  Bat-Chen Friedman; Ayelet Hendeles-Amitai; Ely Kozminsky; Alberto Leiberman; Michael Friger; Ariel Tarasiuk; Asher Tal
Journal:  Sleep       Date:  2003-12-15       Impact factor: 5.849

10.  Increased upper airway collapsibility in children with obstructive sleep apnea during wakefulness.

Authors:  David Gozal; Marilee M Burnside
Journal:  Am J Respir Crit Care Med       Date:  2003-10-02       Impact factor: 21.405

View more
  5 in total

1.  Quantitative Evaluation of the Function of the Sensory Nerve Fibers of the Palate in Patients With Obstructive Sleep Apnea.

Authors:  Yunsong An; Yanru Li; Wei Chang; Fei Gao; Xiu Ding; Wen Xu; Demin Han
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

2.  Airway Resistance in Children with Obstructive Sleep Apnea Syndrome.

Authors:  Ignacio E Tapia; Carole L Marcus; Joseph M McDonough; Ji Young Kim; Mary Anne Cornaglia; Rui Xiao; Julian L Allen
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

3.  Effects of race on upper airway dynamic function during sleep in children.

Authors:  Swaroop Pinto; Jingtao Huang; Ignacio Tapia; Laurie Karamessinis; Michelle Pepe; Paul R Gallagher; Ruth Bradford; Tomas Nixon; Ngoon-Yin Lee; Carole L Marcus
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849

4.  Upper Airway Vibration Perception in School-Aged Children with Obstructive Sleep Apnea.

Authors:  Ignacio E Tapia; Ji Young Kim; Mary Anne Cornaglia; Joel Traylor; George J Samuel; Joseph M McDonough; Carole L Marcus
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

5.  Assessment of Change in Palatal Sensation in Obstructive Sleep Apnea Patients by Using Two-Point Palatal Discrimination.

Authors:  Kyung-Hwa Jeong; Youngsoo Yang; Hye Rang Choi; Jae Hoon Cho; Gee-Tae Kim; Jin Kook Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-04-20       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.